Insert Therapeutics

129 N. Hill Ave. , Suite 104
CA, 91106
United States
PH: (+1) (626) 683 7200
Visit Insert Therapeutics Website or Request Quote for Further Information

Company Background

Insert Therapeutics is focused on designing, developing and commercializing delivery-enhanced therapeutics using our patented class of polymeric delivery systems, which we have called our " Cyclosertâ„¢ " family of linear cyclodextrin-containing polymers. We are developing proprietary Cyclosertâ„¢ -drug conjugates using off-patent compounds that have documented efficacy, but which also have known issues relating to their solubility, stability, undesirable side effects or poor pharmacokinetics that we can improve significantly with Cyclosertâ„¢ .

Insert was founded in February 2000 and is headquartered in Pasadena, California. Insert is a majority-owned subsidiary of Arrowhead Research Corporation.